Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Migraine in Adolescents

NCT: NCT05654012 · RECRUITING

NCT IDNCT05654012
StatusRECRUITING
Start Date2023-06-01
Completion2030-03-15
SponsorWashington University School of Medicine (OTHER)
First posted
Last updated

Brief Summary

Aim 1. To identify psychophysical and neural factors predicting migraine onset in adolescents Aim 2a. To determine hormonal, psychophysical, and neural changes associated with migraine onset. Aim 2b. To identify the temporal relationships between hormonal, psychophysical, and neural changes preceding vs. following migraine onset. Aim 3. To identify psychophysical and neural factors predicting migraine prognosis in adolescents with migraine.

Frequently Asked Questions

What is Migraine in Adolescents?

Migraine in Adolescents is a clinical trial registered under NCT05654012. Current status: RECRUITING.

What is the status of NCT05654012?

The current status of NCT05654012 (Migraine in Adolescents) is: RECRUITING.

When did Migraine in Adolescents start?

Migraine in Adolescents started on 2023-06-01.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.